MIRA Pharmaceuticals(us:MIRA)
1.10
+4.76%
Updated on 2024-12-25
Open:1.07
Close:1.10
High:1.10
Low:1.05
Pre Close:1.05
Volume:209819.00
Amount:227150.73
Turnover:1.27%
Shares:16.56M
MarketCap:18.22M
About MIRA Pharmaceuticals Company
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Company Name: MIRA Pharmaceuticals
Company Address: 1200 Brickell Avenue,Suite 1950 1183
Employees: 3
Fiscar Year: 12-31
IPO Date: 2023-08-03
Website: http://mirapharmaceuticals.com
CIK: 1904286
View all SEC Filings
About
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Address:1200 Brickell Avenue,Suite 1950 1183
Website:http://mirapharmaceuticals.com
Market Movers